Drug intelligence / Profile preview

superparamagnetic iron oxide nanoparticles + C595

Development stage
Preclinical
Modality
Targeted Liposomes → Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Superparamagnetic iron oxide nanoparticles + C595 is a targeted molecular imaging agent consisting of superparamagnetic iron oxide nanoparticles (SPIONs) covalently conjugated to the C595 monoclonal antibody. The C595 antibody specifically binds to the MUC1 antigen, which is overexpressed on certain cancer cells, including breast cancer (MCF-7 cell line). Conjugation is achieved via EDC/NHS-mediated coupling, resulting in a nanoprobe with an average hydrodynamic size of around 87 nm. The primary mechanism is the active targeting of tumor cells through antibody-antigen interaction, followed by selective accumulation of the SPIONs at the target site. In magnetic resonance imaging (MRI), SPIONs act as T2 MRI contrast agents, significantly reducing the T2 relaxation time and enhancing imaging contrast in targeted tissue. The agent demonstrates low cytotoxicity in vitro at studied concentrations and has potential for early diagnosis and molecular imaging of breast cancer[1][3]. C595 is a murine monoclonal antibody developed for mucin (MUC1) targeting.

Other names
SPION-C595SPION-C-595SPION-C 595SPIONs-C595 nanoprobeSPIONs-C-595 nanoprobeSPIONs-C 595 nanoprobe
02

Targets

MUC1 (Mucin-1 Antigen)

Beyond the preview

Go deeper on superparamagnetic iron oxide nanoparticles + C595.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on superparamagnetic iron oxide nanoparticles + C595.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call